X-ray repair cross-complementing group 1 polymorphisms and hepatocellular carcinoma: a meta-analysis (Provisional abstract)      
X-ray repair cross-complementing group 1 (XRCC1) genetic polymorphisms and cervical cancer risk: a HuGE systematic review and meta-analysis (Provisional abstract)      
Xanthine oxidase inhibition for the treatment of cardiovascular disease: a systematic review and meta-analysis (Provisional abstract)      
Xeroderma pigmentosum complementation group D (XPD) gene polymorphisms contribute to bladder cancer risk: a meta-analysis (Provisional abstract)      
Xiangshaliujunzi Decoction for the treatment of diabetic gastroparesis: a systematic review (Provisional abstract)      
Xiaochaihu Tang for treatment of chronic hepatitis B: a systematic review of randomized trials (Provisional abstract)      
Xiaoxuming decoction for acute ischemic stroke: a systematic review and meta-analysis (Provisional abstract)      
Ximelagatran versus warfarin for prophylaxis of venous thromboembolism in major orthopedic surgery: systematic review of randomized controlled trials (Structured abstract)      
Ximelagatran/melagatran against conventional anticoagulation: a meta-analysis based on 22,639 patients (Structured abstract)      
Xingnaojing in the treatment of acute alcohol intoxication: a systematic review (Provisional abstract)      
Xingnaojing injection for intracerebral hemorrhage: a systematic review (Provisional abstract)      
XPC Lys939Gln and Ala499Val polymorphisms in colorectal cancer susceptibility: a meta-analysis of case-control studies (Provisional abstract)      
XPD Asp312Asn and Lys751Gln polymorphisms and breast cancer susceptibility: a meta-analysis (Provisional abstract)      
XPD Lys751Gln and Asp312Asn polymorphisms and gastric cancer susceptibility: a meta-analysis of case-control studies (Provisional abstract)      
Xpert MTB/RIF assay for the diagnosis of extrapulmonary tuberculosis: a systematic review and meta-analysis (Provisional abstract)      New 
XRCC1 and GSTP1 polymorphisms and prognosis of oxaliplatin-based chemotherapy in colorectal cancer: a meta-analysis (Provisional abstract)      
XRCC1 Arg194Trp and Arg280His polymorphisms in bladder cancer susceptibility: a meta-analysis (Provisional abstract)      
XRCC1 Arg194Trp and Arg280His polymorphisms increase bladder cancer risk in Asian population: evidence from a meta-analysis (Provisional abstract)      
The XRCC1 Arg194TRP polymorphism is not a risk factor for glioma: a meta-analysis involving 1,440 cases and 2,562 controls (Provisional abstract)      
XRCC1 Arg280His polymorphism and glioma risk: a meta-analysis involving 1439 cases and 2564 controls (Provisional abstract)      
The XRCC1 Arg280His polymorphism contributes to cancer susceptibility: an update by meta-analysis of 53 individual studies (Provisional abstract)      
XRCC1 Arg399Gln and Arg194Trp polymorphisms in childhood acute lymphoblastic leukemia risk: a meta-analysis (Provisional abstract)      
XRCC1 Arg399Gln and clinical outcome of platinum-based treatment for advanced non-small cell lung cancer: a meta-analysis in 17 studies (Provisional abstract)      
XRCC1 Arg399Gln gene polymorphism and hepatocellular carcinoma risk in the Chinese Han population: a meta-analysis (Provisional abstract)      
XRCC1 Arg399Gln genetic polymorphism and the risk of hepatocellular carcinoma: a meta-analysis (Provisional abstract)      
Xrcc1 arg399gln polymorphism and bladder cancer risk: updated meta-analyses based on 5767 cases and 6919 controls (Provisional abstract)      
XRCC1 gene polymorphisms and lung cancer susceptibility: a meta-analysis of 44 case-control studies (Provisional abstract)      
XRCC1 gene polymorphisms and the risk of differentiated thyroid carcinoma (DTC): a meta-analysis of case-control studies (Provisional abstract)      
XRCC1 polymorphism and prognosis of platinum-based chemotherapy in gastric and colorectal cancer: a meta-analysis (Provisional abstract)      
XRCC1 polymorphisms and cervical cancer risk: an updated meta-analysis (Provisional abstract)      
XRCC1 polymorphisms and differentiated thyroid carcinoma risk: a meta-analysis (Provisional abstract)      
XRCC1 polymorphisms and pancreatic cancer: a meta-analysis (Provisional abstract)      
XRCC1 polymorphisms increase bladder cancer risk in Asians: a meta-analysis (Provisional abstract)      
XRCC3 C18067T polymorphism contributes a decreased risk to both basal cell carcinoma and squamous cell carcinoma: evidence from a meta-analysis (Provisional abstract)      
XRCC3 Thr241Met is associated with response to platinum-based chemotherapy but not survival in advanced non-small cell lung cancer (Provisional abstract)      
XRCC3 Thr241Met polymorphism and clinical outcomes of NSCLC patients receiving platinum-based chemotherapy: a systematic review and meta-analysis (Provisional abstract)      
XRCC3 Thr241Met polymorphism and ovarian cancer risk: a meta-analysis (Provisional abstract)      
The XRCC3 Thr241Met polymorphism influences glioma risk: a meta-analysis (Provisional abstract)      
Xuefuzhuyu decoction for hyperlipidemia: a systematic review and meta-analysis of randomized clinical trials (Provisional abstract)      New 
Xuesaitong soft capsule (Chinese patent medicine) for the treatment of unstable angina pectoris: a meta-analysis and systematic review (Provisional abstract)      
Xuesaitong soft capsule (Chinese patent medicine) for the treatment of unstable angina pectoris: a meta-analysis and systematic review (Provisional abstract)      
Xuezhikang capsule for hyperlipidemia: a systematic review (Provisional abstract)      
Xuezhikang for diabetic kidney disease: a systematic review of randomized controlled trials (Provisional abstract)      
Xylitol as a prophylaxis for acute otitis media: systematic review (Provisional abstract)      
Xysmalobium undulatum (uzara) ? review of an antidiarrhoeal traditional medicine (Provisional abstract)      New